Why is Brooks Lab. falling/rising?

As of 13-Aug, Brooks Laboratories Ltd is experiencing a price increase, currently at 161.00, reflecting a rise of 6.0 or 3.87%. Despite this positive movement today, the stock has shown erratic trading patterns, having not traded on one day out of the last 20 days. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a potential downward trend. Additionally, the delivery volume has significantly decreased by 49.57% compared to the 5-day average, suggesting falling investor participation. However, the company has reported strong financial results, including a 97.76% growth in net profit and positive results for the last three consecutive quarters, which may contribute to the stock's recent upward movement.
In the broader market context, Brooks Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of +3.14% compared to the benchmark's -0.01%. Over the past year, the stock has generated a return of 56.71%, significantly higher than the Sensex's 2.01%. This long-term performance, coupled with the company's strong financial results, positions Brooks Laboratories as a compelling option for investors despite the recent decline in trading activity and liquidity concerns.